Detalles de la búsqueda
1.
Phase II multicentre, double-blind, randomised trial of ustekinumab in adolescents with new-onset type 1 diabetes (USTEK1D): trial protocol.
BMJ Open
; 11(10): e049595, 2021 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34663658
2.
The use of randomisation-based efficacy estimators in non-inferiority trials.
Trials
; 18(1): 117, 2017 03 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28274254
3.
Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.
Sci Transl Med
; 9(402)2017 08 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28794283
4.
Electronic monitoring of medication adherence in a 1-year clinical study of 2 dosing regimens of mesalazine for adults in remission with ulcerative colitis.
Inflamm Bowel Dis
; 20(1): 82-91, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24284414
5.
One-year investigator-blind randomized multicenter trial comparing Asacol 2.4 g once daily with 800 mg three times daily for maintenance of remission in ulcerative colitis.
Inflamm Bowel Dis
; 18(10): 1885-93, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22081522
6.
A new protocol for the in situ generation of aromatic, heteroaromatic, and unsaturated diazo compounds and its application in catalytic and asymmetric epoxidation of carbonyl compounds. Extensive studies to map out scope and limitations, and rationalization of diastereo- and enantioselectivities.
J Am Chem Soc
; 125(36): 10926-40, 2003 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-12952474
Resultados
1 -
6
de 6
1
Próxima >
>>